SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-11-015414
Filing Date
2011-03-17
Accepted
2011-03-17 06:05:51
Documents
3
Group Members
MANGROVE CAPITALMANGROVE PARTNERS

Document Format Files

Seq Description Document Type Size
1 v215028_sc13da.htm SC 13D/A 88108
2 v215028_ex99-1.htm EX-99.1 92636
3 GRAPHIC logo.jpg GRAPHIC 3457
  Complete submission text file 0001144204-11-015414.txt   187170
Mailing Address 2 HOLLAND WAY EXETER NH 03833
Business Address 2 HOLLAND WAY EXETER NH 03833 (603) 658-6100
CPEX Pharmaceuticals, Inc. (Subject) CIK: 0001418919 (see all company filings)

IRS No.: 261172076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-84092 | Film No.: 11693569
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 W. 58TH STREET SUITE 8F NEW YORK NY 10019
Business Address 100 W. 58TH STREET SUITE 8F NEW YORK NY 10019 (646) 450-0418
Mangrove Partners Fund, L.P. (Filed by) CIK: 0001486623 (see all company filings)

IRS No.: 272067192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A